Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

Publication | Closed Access

DOI

422

Citations

References

2012

Year

Robert P. Giugliano, Nihar R. Desai, Payal Kohli, William J. Rogers, Ransi Somaratne, Fannie Huang, Thomas Liu, Satishkumar Mohanavelu, Elaine Hoffman, Shannon T McDonald,

The Lancet

ThrombosisLipid DisorderCardiovascular DiseaseLaplace-timi 57HyperlipidemiaDyslipidemiaMedicineAtherosclerosisMonoclonal Antibody